Written by Recent advancements in lung cancer treatment have led to the development of several innovative therapies that offer hope for improved patient outcomes. These treatments encompass novel drug combinations, targeted therapies, and immunotherapies, each designed to address specific genetic mutations and tumor characteristics. 1. Amivantamab and Osicent 80 mg (Osimertinib) Combination: A groundbreaking combination of amivantamab, […]